Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: Case report and review of the literature

Arthritis Care and Research

Volumn 51, Issue 4, 2004, Pages 670-673

  Szalat, Auryan ^a   Krasilnikov, Irena ^a   Bloch, Aharon ^a   Meir, Karen ^a   Rubinger, Dvora ^a   Mevorach, Dror ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

ACUTE KIDNEY FAILURE; ADULT; BACKACHE; CASE REPORT; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; EOSINOPHILIA; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; LIVER TOXICITY; LUMBAR DISK HERNIA; LUMBAR SPINE; NEUROTOXICITY; PAIN; RASH; REVIEW;

EID: 4043182608     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20543     Document Type: Review

References (25)

1. Schlondorff D. Renal complications of non steroidal anti-inflammatory drugs. Kidney Int 1993;44:643-53.
2. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1984;310:563-72.
3. Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991;114:307-19.
4. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993;153:477-84.
5. Feenstra J, Heerdink ER, Grobbee DE, Stricker BH. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med 2002;162:265-70.
6. Abramson SB. Mechanisms of action of nonsteroidal anti-inflammatory drugs and therapeutic considerations. Bull Hosp Jt Dis Orthop Inst 1990;50:107-15.
7. Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol 1997;272:F460-8.
8. Brater DC, Harris C, Redfern JS, Gertz BJ. Renal effects of COX-2-selective inhibitors. Am J Nephrol 2001;21:1-15.
9. Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, et al. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther 2002;72:50-61.
10. Niccoli L, Bellino S, Cantini F. Renal tolerability of three commonly employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis. Clin Exp Rheumatol 2002;20:201-7.
11. Truitt KE, Sperling RS, Ettinger WH Jr, Greenwald M, DeTora L, Zeng Q, et al. A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis. Aging (Milano) 2001;13:112-21.
12. Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, et al. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet: a randomized, controlled trial. Ann Intern Med 2000;133:1-9.
13. Perazella MA. COX-2 selective inhibitors: analysis of the renal effects. Expert Opin Drug Saf 2002;1:53-64.
14. Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu Rev Pharmacol Toxicol 1993;33:435-65.
15. Gambaro G, Perazella MA. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med 2003;253:643-52.
16. Rocha JL, Fernandez-Alonso J. Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib. Lancet 2001;357:1946-7.
17. Alper AB Jr, Meleg-Smith S, Krane NK. Nephrotic syndrome and interstitial nephritis associated with celecoxib. Am J Kidney Dis 2002;40:1086-90.
18. Markowitz GS, Falkowitz DC, Isom R, Zaki M, Imaizumi S, Appel GB, et al. Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. Clin Nephrol 2003;59:137-42.
19. Henao J, Hisamuddin I, Nzerue CM, Vasandani G, Hewan-Lowe K. Celecoxib-induced acute interstitial nephritis. Am J Kidney Dis 2002;39:1313-7.
20. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001;60:804-17.
21. Rastegar A, Kashgarian M. The clinical spectrum of tubulointerstitial nephritis. Kidney Int 1998;54:313-27.
22. Porile JL, Bakris GL, Garella S. Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti-inflammatory agents: a review of its clinical spectrum and effects of steroid therapy. J Clin Pharmacol 1990;30:468-75.
23. Bennett WM, Henrich WL, Stoff JS. The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am J Kidney Dis 1996;28:S56-62.
24. Ravnskov U. Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs: evidence of a common mechanism. Br J Clin Pharmacol 1999;47:203-10.
25. Kesler A, Goldhammer Y, Gadoth N. Do men with pseudotumor cerebri share the same characteristics as women: a retrospective review of 141 cases. J Neuroophthalmol 2001;21:15-7.